Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):411-6. doi: 10.1097/MPG.0b013e3181cb42ee.

Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis.

Author information

1
Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.

Abstract

BACKGROUND:

Biliary atresia (BA) is the most serious liver disease in infants. Diagnosis currently depends on surgical exploration of the biliary tree. Noninvasive tests that distinguish BA from other types of neonatal liver disease are not available.

PATIENTS AND METHODS:

To identify potential serum biomarkers that classify children with neonatal cholestasis, we performed 2-dimensional difference gel electrophoresis, statistical analysis, and tandem mass spectrometry using serum samples from 19 infants with BA and 19 infants with non-BA neonatal cholestasis.

RESULTS:

Eleven potential serum biomarkers were found that could in combination classify children with neonatal cholestasis.

CONCLUSIONS:

Although no single biomarker or imaging test adequately distinguishes BA from other types of neonatal cholestasis, combinations of biomarkers, imaging tests, and noninvasive clinical criteria should be further explored as potential tests for rapid and accurate diagnosis of BA.

PMID:
20216099
PMCID:
PMC2881691
DOI:
10.1097/MPG.0b013e3181cb42ee
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins Icon for PubMed Central
    Loading ...
    Support Center